Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
Ambaw BelleteOfficer | CG OncologyCGON | 30,787 sh | $2,340,024.43 | 09/21 | Filed 09/21 |
Ambaw BelleteOfficer | CG OncologyCGON | 6,532 sh | $499,698 | 09/17 | Filed 09/17 |
Ambaw BelleteOfficer | CG OncologyCGON | 826 sh | $61,950 | 09/11 | Filed 09/11 |
Ambaw BelleteOfficer | CG OncologyCGON | 29,630 sh | $2,299,448 | 09/02 | Filed 09/02 |
Ambaw BelleteOfficer | CG OncologyCGON | 50,000 sh | $3,775,250 | 08/31 | Filed 08/31 |
Ambaw BelleteOfficer | CG OncologyCGON | 5,789 sh | $459,560.92 | 08/27 | Filed 08/27 |
Ambaw BelleteOfficer | CG OncologyCGON | 10,551 sh | $839,338.38 | 08/25 | Filed 08/25 |
Ambaw BelleteOfficer | CG OncologyCGON | 5,762 sh | $458,185.02 | 08/24 | Filed 08/24 |
Ambaw BelleteOfficer | CG OncologyCGON | 100,000 sh | $7,954,105 | 08/19 | Filed 08/19 |
Ambaw BelleteOfficer | CG OncologyCGON | 52,438 sh | $4,034,894.35 | 08/17 | Filed 08/17 |
Ambaw BelleteOfficer | CG OncologyCGON | 19,364 sh | $1,452,635 | 08/14 | Filed 08/14 |
Ambaw BelleteOfficer | CG OncologyCGON | 25,989 sh | $1,973,970.86 | 08/13 | Filed 08/13 |
Ambaw BelleteOfficer | CG OncologyCGON | 32,137 sh | $2,526,514.53 | 08/12 | Filed 08/12 |
Ambaw BelleteOfficer | CG OncologyCGON | 50,000 sh | $3,810,255 | 08/11 | Filed 08/11 |
Ambaw BelleteOfficer | CG OncologyCGON | 50,000 sh | $3,770,580 | 08/10 | Filed 08/10 |
Ambaw BelleteOfficer | CG OncologyCGON | 9,250 sh | $696,062.5 | 08/07 | Filed 08/07 |
Ambaw BelleteOfficer | CG OncologyCGON | 75,000 sh | $5,672,212.5 | 08/06 | Filed 08/06 |
Ambaw BelleteOfficer | CG OncologyCGON | 25,000 sh | $1,837,500 | 08/05 | Filed 08/05 |
Ambaw BelleteOfficer | CG OncologyCGON | 4,303 sh | $316,270.5 | 07/29 | Filed 07/29 |
Ambaw BelleteOfficer | CG OncologyCGON | 50,000 sh | $3,625,195 | 07/28 | Filed 07/28 |